糞便微生物移植の現状と未来

強毒変異株の出現を契機に,難治性の再発性クロストリジウム・ディフィシル感染症(recurrent Clostridium difficile infection:rCDI)が欧米で猛威をふるっている.2013年にオランダのグループがrCDIを対象とした糞便微生物移植(fecal microbiota transplantation:FMT)の臨床試験で画期的な有効性を証明したことで,FMTに注目が集まることとなった.rCDI以外に,炎症性腸疾患,過敏性腸症候群(irritable bowel syndrome:IBS)をはじめとしたさまざまな消化管疾患や肝疾患・精神神経系疾患等も含めた多くの疾...

Full description

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 107; no. 10; pp. 2176 - 2182
Main Authors 水野, 慎大, 金井, 隆典
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 10.10.2018
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.107.2176

Cover

Abstract 強毒変異株の出現を契機に,難治性の再発性クロストリジウム・ディフィシル感染症(recurrent Clostridium difficile infection:rCDI)が欧米で猛威をふるっている.2013年にオランダのグループがrCDIを対象とした糞便微生物移植(fecal microbiota transplantation:FMT)の臨床試験で画期的な有効性を証明したことで,FMTに注目が集まることとなった.rCDI以外に,炎症性腸疾患,過敏性腸症候群(irritable bowel syndrome:IBS)をはじめとしたさまざまな消化管疾患や肝疾患・精神神経系疾患等も含めた多くの疾患においても,FMTの有用性を探る試みが続けられている.本稿では,rCDIにおけるFMTの成功から5年が経過し,研究の進展に伴って徐々に概念が変化しつつあるFMTの歴史と現状を解説し,将来を見据えたFMTの位置付けについて議論してみたい.
AbstractList 強毒変異株の出現を契機に,難治性の再発性クロストリジウム・ディフィシル感染症(recurrent Clostridium difficile infection:rCDI)が欧米で猛威をふるっている.2013年にオランダのグループがrCDIを対象とした糞便微生物移植(fecal microbiota transplantation:FMT)の臨床試験で画期的な有効性を証明したことで,FMTに注目が集まることとなった.rCDI以外に,炎症性腸疾患,過敏性腸症候群(irritable bowel syndrome:IBS)をはじめとしたさまざまな消化管疾患や肝疾患・精神神経系疾患等も含めた多くの疾患においても,FMTの有用性を探る試みが続けられている.本稿では,rCDIにおけるFMTの成功から5年が経過し,研究の進展に伴って徐々に概念が変化しつつあるFMTの歴史と現状を解説し,将来を見据えたFMTの位置付けについて議論してみたい.
Author 金井, 隆典
水野, 慎大
Author_xml – sequence: 1
  fullname: 水野, 慎大
  organization: 慶應義塾大学内科学(消化器)
– sequence: 1
  fullname: 金井, 隆典
  organization: 慶應義塾大学内科学(消化器)
BookMark eNo9jz1LxEAQhhc5wXhe61-wyjmb3SSzpQS_4MBG6zBJNpp4RkmusbxSQWws_WgUP4prBBsh_pjT7N8wnmLx8vDOwDDPIusUx4VmbJlD3-GeWi0oO6Q-B7-tvjfHLI4obAdQdJgF4HDbFSgXWK-qsgik8FzkQlpsxbzeftYfX_XEXN2Zs2fz-N7cX0zHE3NZm_O36fipuX5pbh6W2HxKw0r3_thlexvru8GWPdjZ3A7WBnbuOD7YHN0IRaIiiLSIZZSShsRViUxSIM4VoMR2ImUKnmofR-VJFFrFjs-ROIkuC37v5tWI9nV4UmZHVJ6GVI6yeKjDmWfYeraZ4Uf3fxsfUBnmJL4BFnhd5A
ContentType Journal Article
Copyright 2018 一般社団法人 日本内科学会
Copyright_xml – notice: 2018 一般社団法人 日本内科学会
DOI 10.2169/naika.107.2176
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 2182
ExternalDocumentID article_naika_107_10_107_2176_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ID FETCH-LOGICAL-j2270-185b83d9b0be3c4bfae0d59d4df0a1190848e0d44f069216896483e9c2718a1a3
ISSN 0021-5384
IngestDate Wed Sep 03 06:29:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 10
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2270-185b83d9b0be3c4bfae0d59d4df0a1190848e0d44f069216896483e9c2718a1a3
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/107/10/107_2176/_article/-char/ja
PageCount 7
ParticipantIDs jstage_primary_article_naika_107_10_107_2176_article_char_ja
PublicationCentury 2000
PublicationDate 2018/10/10
PublicationDateYYYYMMDD 2018-10-10
PublicationDate_xml – month: 10
  year: 2018
  text: 2018/10/10
  day: 10
PublicationDecade 2010
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2018
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 8) Maldonado-Gómez MX, et al: Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20: 515-526, 2016.
10) Ott SJ, et al: Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology 152: 799-811, 2017.
2) Beck DA, et al: Coprophagia in an elderly man: a case report and review of the literature. Int J Psychiatry Med 35: 417-427, 2005.
1) van Nood E, et al: Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368: 407-415, 2013.
7) Ridaura VK, et al: Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214, 2013.
4) Mizuno S, et al: Bifidobacterium-rich fecal donor may be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome. Digestion 96: 29-38, 2017.
6) Johnsen PH, et al: Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol 3: 17-24, 2018.
5) Paramsothy S, et al: Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389: 1218-1228, 2017.
3) Kao D, et al: Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 318: 1985-1993, 2017.
9) Li SS, et al: Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352: 586-589, 2016.
References_xml – reference: 5) Paramsothy S, et al: Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389: 1218-1228, 2017.
– reference: 1) van Nood E, et al: Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368: 407-415, 2013.
– reference: 4) Mizuno S, et al: Bifidobacterium-rich fecal donor may be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome. Digestion 96: 29-38, 2017.
– reference: 9) Li SS, et al: Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352: 586-589, 2016.
– reference: 6) Johnsen PH, et al: Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol 3: 17-24, 2018.
– reference: 8) Maldonado-Gómez MX, et al: Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20: 515-526, 2016.
– reference: 7) Ridaura VK, et al: Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214, 2013.
– reference: 3) Kao D, et al: Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 318: 1985-1993, 2017.
– reference: 2) Beck DA, et al: Coprophagia in an elderly man: a case report and review of the literature. Int J Psychiatry Med 35: 417-427, 2005.
– reference: 10) Ott SJ, et al: Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology 152: 799-811, 2017.
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 2.1813116
Snippet 強毒変異株の出現を契機に,難治性の再発性クロストリジウム・ディフィシル感染症(recurrent Clostridium difficile infection:rCDI)が欧米で猛威をふるっている.2013...
SourceID jstage
SourceType Publisher
StartPage 2176
SubjectTerms dysbiosis
クロストリジウム・ディフィシル感染症
糞便微生物移植
Title 糞便微生物移植の現状と未来
URI https://www.jstage.jst.go.jp/article/naika/107/10/107_2176/_article/-char/ja
Volume 107
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2018/10/10, Vol.107(10), pp.2176-2182
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1883-2083
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib007485360
  issn: 0021-5384
  databaseCode: KQ8
  dateStart: 19130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07j9QwEI6OQ0I0iKd46wosCpQljh8ZSzTOXlYn4JCQ7qTroiSbLbZYENpr6K4ECdFQ8mhAPIprkGiQlh9zsPkbzDjZ3ax0BXc0kWOPP48zjvzZGo8975bIdF5EJfhFVka-DAvuI8vnfp5HvN8P0eI5nR3efKQ3tuX9HbWzcuJhy2tpd5x3iueHnis5jlUxD-1Kp2SPYNk5KGZgGu2LT7QwPv_JxiyJWCyYSVgiWZywuMcSRQmbUJGRzPQoAYZZQwmL8jFLNLNIIddZIpBINsLQo4qUsCzWsyIgYdNl1rrEOrOqTWddJsKqmViXFADNQDXNGU45Fitqp2SXGYQyzMSuCAgZ5ju1BBMHLJYkAqiL89WkXATEF4KSCLuQd2KEhNiWGVXLG2oF1SBl8INAe2-Du0CzjZcrjUZXF8jlA9UBcJ2IqJ3YNYiaWuEUE4RfNxTbO8fre3uWCLmPE0G90VHWEwOAwLFXX7oznznqC3tnv0iwNBFEukUqKE7-YRNWyDXFex3RcbEOwnUW9ZaCgDdDLHWCKQqmznkgSkk-nZXSQb10iKuFk2GkJW1FPHjcIttGUgC5FjmDpbsFcPHN28EBFUSmfRdCJJHaLepLgeSVL4ILIpM1AvQ8eBs5T9f3hzRfsw6ZSj2-u9xfJH9DXArN3Cgds9s6651plmRrtu7eOW9lmJ33Tm02TicXvNvV9_e_J7_-TParNx-qF1-rzz-nH18d7O1XryfVyx8He1-mb79N33266G33kq3uht_cL-IPwzAilwaVg-ibPMhLUch8kJVBX5m-7A-CjCNTBgmYI-Ug0Ab1BqMliNIUIRK6jGfikrc6ejIqL3trqgQeCCmCgiJaBipXemAkgsoMCbXJrnj36i6mT-sgMumRLHr1_6pf804v_q7r3ur42W55A7n0OL_phshfGpKYeg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%B3%9E%E4%BE%BF%E5%BE%AE%E7%94%9F%E7%89%A9%E7%A7%BB%E6%A4%8D%E3%81%AE%E7%8F%BE%E7%8A%B6%E3%81%A8%E6%9C%AA%E6%9D%A5&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E6%B0%B4%E9%87%8E%2C+%E6%85%8E%E5%A4%A7&rft.au=%E9%87%91%E4%BA%95%2C+%E9%9A%86%E5%85%B8&rft.date=2018-10-10&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=107&rft.issue=10&rft.spage=2176&rft.epage=2182&rft_id=info:doi/10.2169%2Fnaika.107.2176&rft.externalDocID=article_naika_107_10_107_2176_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon